Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check11 days agoChange DetectedStatus indicators were updated to show 'Results Submitted' and 'Revision: v3.4.3'. The previous 'No Results Posted' and 'Revision: v3.4.2' indicators were removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous operating-status notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check47 days agoChange DetectedA site-wide notice about government funding and a version update from v3.4.0 to v3.4.1 appear on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedShow glossary is now enabled on the page, and the label for the updated QC metric has been changed to 'Last Update Submitted that Met QC Criteria'. The footer now includes 'No FEAR Act Data' and the page revision shows 'Revision: v3.4.0'.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, indicating a small metadata update with no substantive changes to the study information.SummaryDifference0.1%

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.